4//SEC Filing
Obrocea Mihail 4
Accession 0001127602-23-017885
CIK 0001878313other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:23 PM ET
Size
5.1 KB
Accession
0001127602-23-017885
Insider Transaction Report
Form 4
Obrocea Mihail
Chief Medical Officer
Transactions
- Award
Stock Options
2023-05-31+87,495→ 87,495 totalExercise: $2.50From: 2023-05-31Exp: 2032-05-30→ Common Stock (87,495 underlying)
Footnotes (1)
- [F1]The stock options, granted on May 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001913265
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 5:23 PM ET
- Size
- 5.1 KB